- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
c-RET antibody recognizes receptor tyrosine kinase RET, a single-pass transmembrane protein that mediates ligand-induced signal transduction. RET contains an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyrosine kinase domain responsible for autophosphorylation and activation of downstream signaling pathways. Activation of receptor tyrosine kinase RET occurs upon binding of glial cell line-derived neurotrophic factor family ligands in conjunction with GFR alpha co-receptors.
Following activation, RET stimulates MAPK, PI3K-AKT, PLC gamma, and STAT pathways that regulate cell survival, proliferation, and differentiation. Receptor tyrosine kinase RET plays essential roles in neural crest cell development, kidney organogenesis, and enteric nervous system formation. Dysregulated RET signaling contributes to cancer progression, particularly in thyroid carcinomas and lung cancers harboring RET rearrangements or activating mutations.
c-RET antibody is suitable for detecting receptor tyrosine kinase RET in studies of growth factor signaling, kinase activation, and targeted therapeutic research. Detection of RET expression supports investigation of receptor-mediated oncogenic pathways and signaling dynamics.
Optimal dilution of the c-RET/Receptor Tyrosine Kinase RET antibody should be determined by the researcher.
A recombinant partial protein (within amino acids 702-848) from the human protein was used as the immunogen for the c-RET/Receptor Tyrosine Kinase RET antibody.
Aliquot the c-RET/Receptor Tyrosine Kinase RET antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.